BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9026851)

  • 41. Cell kinetics with in vivo bromodeoxyuridine assay, proliferating cell nuclear antigen expression, and flow cytometric analysis. Prognostic significance in acute nonlymphoblastic leukemia.
    Giordano M; Danova M; Mazzini G; Gobbi P; Riccardi A
    Cancer; 1993 May; 71(9):2739-45. PubMed ID: 8096794
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic usefulness of lysozyme in acute myelomonocytic leukemias].
    Liso V; Laricchia R
    Minerva Med; 1983 Jun; 74(27):1595-600. PubMed ID: 6574344
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of general immune competence in acute leukemia.
    Li BL; Hu J; Ye J; Wang XF; Shen YG; Li BB; Chen YC; Lin XS; Chen YQ
    Med Oncol Tumor Pharmacother; 1990; 7(4):233-9. PubMed ID: 2283891
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prognosis of recurrences and analysis of factors affecting the survival of patients with acute leukemia].
    Osmanov DSh; Perilov AA; Volkova MA
    Ter Arkh; 1983; 55(8):19-23. PubMed ID: 6579693
    [No Abstract]   [Full Text] [Related]  

  • 45. Prognostic factors affecting remission, remission duration, and survival in adult acute nonlymphocytic leukemia.
    Brandman J; Bukowski RM; Greenstreet R; Hewlett JS; Hoffman GC
    Cancer; 1979 Sep; 44(3):1062-5. PubMed ID: 289433
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prognostic value of selected hematological parameters in patients with acute leukemia].
    Kordecki H
    Ann Acad Med Stetin; 1982; 28():273-84. PubMed ID: 6963106
    [No Abstract]   [Full Text] [Related]  

  • 47. Analysis of prognostic factors in acute leukemias in adults.
    Krykowski E; Polkowska-Kulesza E; Robak T; Matusewicz W; Urbańska-Rys H; Hołub A
    Haematol Blood Transfus; 1987; 30():369-72. PubMed ID: 3476368
    [No Abstract]   [Full Text] [Related]  

  • 48. [Morphocytochemical and immunological criteria for the diagnosis and prognosis of the course of acute myelogenous. leukemias].
    Shakhbazian GP; Dul'tsina SM; Potapova SG; Abakumov EM; Isaev VG
    Probl Gematol Pereliv Krovi; 1982 Nov; 27(11):17-22. PubMed ID: 6961396
    [No Abstract]   [Full Text] [Related]  

  • 49. Acute myeloid leukemia in elderly patients: results of chemotherapy and prognostic factors.
    Reiffers J; Bernard P; David B; Vezon G; Broustet A
    Haematologica; 1983; 68(2):214-25. PubMed ID: 6407916
    [No Abstract]   [Full Text] [Related]  

  • 50. [Blast stage in chronic myeloleukemia--diagnostic and therapeutic problems].
    Atanasova L; Apostolov P; Dimova R; Mladenov B
    Vutr Boles; 1984; 23(4):83-8. PubMed ID: 6594827
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2' and 3' ribonucleoside monophosphate in leukocytes of acute myeloid leukemia: markers for early diagnosis of relapse.
    Scavennec J; Cailla H; Gastaut JA; Maraninchi D; Carcassonne Y
    Int J Cancer; 1982 Mar; 29(3):257-9. PubMed ID: 6279525
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and prognostic significance of the kinetic parameters of tumor growth in acute leukemia].
    Vladimirskaia EB; Koshel' IV; Kurmashov VI; Zamaraeva NV; Averbakh AV
    Probl Gematol Pereliv Krovi; 1981 Jul; 26(7):14-9. PubMed ID: 7279890
    [No Abstract]   [Full Text] [Related]  

  • 53. [Analysis of prognostic variables in childhood acute myeloid leukemia].
    Gu LJ; Tie LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J; Ye H; Wang YP; Dong L
    Zhonghua Xue Ye Xue Za Zhi; 2006 Jan; 27(1):10-3. PubMed ID: 16732931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ; Gu LJ; Song DL; Xue HL; Tang JY; Dong L; Pan C; Chen J; Ye H; Chen J; Wang YP; Zou JY
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(26):1837-40. PubMed ID: 17054861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Current therapeutic strategies in the management of acute myeloid leukemia].
    Fiegl M; Hiddemann W; Braess J
    Med Klin (Munich); 2007 Apr; 102(4):309-16. PubMed ID: 17426934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Prognostic factors in acute nonlymphoid leukemias].
    Capelli D; Tedeschi A; Montillo M; Corvatta L; Bartocci C; Montroni M; Leoni P
    Recenti Prog Med; 1996 Oct; 87(10):466-70. PubMed ID: 9026851
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.